Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Kilimanjaro IPTi Drug Options Trial [Phase 2, Phase 3]

View source ↗

Summary

The Kilimanjaro IPTi Drug Options trial, sponsored by the London School of Hygiene and Tropical Medicine, completed Phase 2 and Phase 3 studies evaluating inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: COMPLETED